Cargando…
Association of APOE4 genotype and treatment with cognitive outcomes in breast cancer survivors over time
This prospective longitudinal study of breast cancer survivors (n = 167) examined the association of apolipoprotein ε4 (APOE ε4) genotype with cognition and interactions with chemotherapy or endocrine therapy up to 6 years after treatment. In general, we found no effects of ε4 across timepoints and...
Autores principales: | Van Dyk, Kathleen, Crespi, Catherine M., Bower, Julienne E., Carroll, Judith E., Petersen, Laura, Ganz, Patricia A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417038/ https://www.ncbi.nlm.nih.gov/pubmed/34480030 http://dx.doi.org/10.1038/s41523-021-00327-4 |
Ejemplares similares
-
Cognitive function following breast cancer treatment and associations with concurrent symptoms
por: Van Dyk, Kathleen, et al.
Publicado: (2018) -
Identifying Cancer-Related Cognitive Impairment Using the FACT-Cog Perceived Cognitive Impairment
por: Dyk, Kathleen Van, et al.
Publicado: (2019) -
Psychosocial Resilience to Inflammation-Associated Depression: A
Prospective Study of Breast-Cancer Survivors
por: Manigault, Andrew W., et al.
Publicado: (2022) -
Protective Effects of APOE ε2 Genotype on Cognition in Older Breast Cancer Survivors: The Thinking and Living With Cancer Study
por: Van Dyk, Kathleen, et al.
Publicado: (2021) -
Screening for Depression in Younger Breast Cancer Survivors: Outcomes From Use of the 9-item Patient Health Questionnaire
por: Ganz, Patricia A, et al.
Publicado: (2021)